[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"facial-paralysis-peripheral\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:facial-paralysis-peripheral":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,46,69],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100634264","the-efficacy-of-intradermal-acupuncture-for-ocular-surface-diseases-after-intractable-facial-paralysis-100634264",false,"NCT07537426","The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis","Inclusion Criteria:\n\n* 1.Male or female patients aged 18-65 years.\n* 2.Meets diagnostic criteria for intractable peripheral facial paralysis, with disease duration from 1 month to 1 year. FNGS 2.0 ≥15 points; ENoG shows the ratio of CMAP amplitude≤ 20%.\n* 3.At least one subjective ocular symptom (dryness, foreign body sensation, burning, fatigue, redness, fluctuating vision) and OSDI scores between 30 and 80.\n* 4.Voluntarily provides written informed consent and can comply with treatment and follow-up.\n\nExclusion Criteria:\n\n* 1.Other ocular diseases (glaucoma, keratitis, retinopathy, acute inflammation of conjunctiva, sclera, cornea).\n* 2\\. Intraocular surgery or laser therapy within the past 90 days.\n* 3.Use of systemic or topical antibiotics or tear-affecting drugs within 3 weeks; dry eye medications within 2 weeks.\n* 4.Lacrimal passage obstruction, dacryocystitis, punctal occlusion, or neurological impairment preventing full eyelid closure.\n* 5.Coagulation disorders, open wounds, or local infection at intervention sites.\n* 6.Allergy to press-needle materials (stainless steel, adhesive tape).\n* 7.Pregnancy or lactation.\n* 8.Severe cardiac, hepatic, renal, psychiatric disorders, or malignant tumors.\n* 9.Participation in another clinical trial within the past month.","ALL","18 Years","65 Years",{"count":19,"type":20},78,"ESTIMATED","INTERVENTIONAL",[23],"NA","The purpose of this study is to explore the clinical efficacy of intradermal acupuncture in the treatment of ocular surface diseases after Intractable Facial Paralysis, and to seek effective and convenient treatment for ocular surface diseases after intractable peripheral facial paralysis. The main question it aims to answer is ： Will the intradermal acupuncture intervention effectively reduce the OSDI score ? The researchers compared the intradermal acupuncture with the placebo-needle to observe whether the intradermal acupuncture could better improve the symptoms.",[26,27,28],"Facial Paralysis, Peripheral","Bell's Palsy","Ocular Surface Disease",[30,31,32],"sequelae of facial paralysis","ocular surface disease","intradermal acupuncture","RECRUITING","2026-04-12",{"date":36,"type":37},"2026-04-17","ACTUAL",{"date":39,"type":37},"2026-04-01",{"date":41,"type":20},"2028-03-25",{"name":43,"class":44},"The First Affiliated Hospital of Zhejiang Chinese Medical University","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":15,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":45},"100432025","the-effectiveness-and-safety-of-integrative-korean-medicine-treatment-for-bells-palsy-100432025","NCT04905745","The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy","The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy : A Prospective Observational Preliminary Study","Inclusion Criteria:\n\n1. age of 19 to 69\n2. diagnosed with unilateral peripheral facial nerve palsy\n3. onset of facial palsy within 3 weeks or less.\n4. an individual who can provide written consent form to participate in the study.\n\nExclusion Criteria:\n\n1. diagnosed with central nervous system disease causing facial palsy\n2. secondary facial palsy after multiple sclerosis, tumor, cerebrovascular disease and temporal bone fracture.\n3. Ramsay-Hunt syndrome\n4. bilateral or recurrent facial nerve palsy.\n5. an individual who received any treatment that can have a significant effect on changes in facial paralysis within recent 2 month. (ie. facial nerve decompression surgery)\n6. already or planned to be pregnant or breast-feeding within the study period.\n7. uncontrolled diabetes mellitus within the last 3 months.\n8. within a month after participating any other facial palsy-related clinical trials, or planning to participate other clinical trials within 6 month.\n9. impossible to read and understand the documents, regarding informed consent form and the questionnaires.\n10. difficult to participate according to the judgement of researchers.","19 Years","69 Years",{"count":56,"type":20},100,"OBSERVATIONAL","This is an observational study that evaluate the effectiveness and safety of Korean integrative treatments in patients with peripheral facial nerve palsy. Adulthood patients aged between 19 to 69 who were diagnosed with peripheral facial nerve palsy and receive Korean integrative treatments for facial palsy will be enrolled in the study and the change will be followed according to the Facial disability index (FDI) at the 3 month moment after baseline.",[26],"2026-02-24",{"date":62,"type":37},"2026-02-25",{"date":64,"type":37},"2021-05-25",{"date":66,"type":20},"2027-08-31",{"name":68,"class":44},"Jaseng Medical Foundation",{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":4,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":15,"minAge":16,"maxAge":76,"enrollmentInfo":77,"targetDuration":79,"studyType":57,"phases":4,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":5},"100573153","the-relationship-between-idiopathic-acute-peripheral-facial-paralysis-and-homocysteine-level-in-adult-patients-100573153","NCT06742580","The Relationship Between Idiopathic Acute Peripheral Facial Paralysis and Homocysteine Level in Adult Patients","Inclusion Criteria:\n\n\\- Patients admitted with acute facial paralysis\n\nExclusion Criteria:\n\n* Facial and ear trauma or tumor\n* İatrogenic\n* Cholesteatoma\n* Facial paralysis due to central nervous system diseases",true,"80 Years",{"count":78,"type":20},80,"2 Months","In the etıology of Idıopathıc Acute Perıpheral Facıal Palsy, known as bell palsy, many causes have been descrıbed, such as specıfıc ımmune, ıchemıc, ınfectıous and heredıal factors. ın our study, we have observed the blood homocysteıne level that causes thrombotıc dısorders ın paralysıs patıents.",[26,82],"Bell Palsy",[84,85,82],"Acute Peripheral Facial Paralysis","Homocysteine","2024-12-18",{"date":88,"type":37},"2024-12-19",{"date":90,"type":37},"2023-12-01",{"date":92,"type":20},"2025-08-04",{"name":94,"class":44},"Murat Akın"]